Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: Study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)

Trials

Volumn 14, Issue 1, 2013, Pages

  Hou, Ya Zhu ^a   Wang, Shuai ^a   Zhao, Zhi Qiang ^a   Wang, Xian Liang ^a   Li, Bin ^a   Soh, Shan Bin ^a   Mao, Jing Yuan ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

6 minute walking test; Ischemic heart failure; Qishen Yiqi dripping pills; Traditional Chinese medicine

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LIPID; PLACEBO; PLANT MEDICINAL PRODUCT; QISHEN YIQI; UNCLASSIFIED DRUG; VASODILATOR AGENT;

6 MINUTE WALKING TEST; ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; CARDIOVASCULAR DISEASE; CHINA; CHINESE MEDICINE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EMERGENCY CARE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART FAILURE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINNESOTA QUALITY OF LIFE INDEX; MORTALITY; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PILL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE INDEX; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION;

BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CHINA; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HOSPITALIZATION; HUMANS; LIPIDS; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; RECOVERY OF FUNCTION; RESEARCH DESIGN; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; WALKING;

EID: 84879029596     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-138     Document Type: Article

References (28)

1. Murdoch DR, Love MP, Robb SD, McDonagh TA, Davie AP, Ford I, Capewell S, Morrison CE, McMurray JJ. Importance of heart failure as a cause of death: changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. Eur Heart J 1998, 19:1829-1835. 10.1053/euhj.1998.1269, 9886726.
2. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med 1999, 159:29-34. 10.1001/archinte.159.1.29, 9892327.
3. Fox KF, Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR, Turner RM, Poole-Wilson PA, Davies SW, Sutton GC. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001, 22:228-236. 10.1053/euhj.2000.2289, 11161934.
4. Smith WM. Epidemiology of congestive heart failure. Am J Cardiol 1985, 55(suppl A):3A-8A.
5. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN, Heart Failure Society of America HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010, 16(6):1-194. 10.1016/j.cardfail.2010.04.004, 20123311, Heart Failure Society of America.
6. Chinese Society of Cardiology, Chinese Journal of Cardiology editorial committee 2007 CSC guidelines for the treatment and diagnosis of chronic heart failure. Chin J Cardiol 2007, 35(12):1076-1095. Chinese Society of Cardiology, Chinese Journal of Cardiology editorial committee.
7. Cui XL, Mao JY, Wang XL, Wang HH, Li GZ, Liu HW, Zhang FL, Cai H. Analysis of experts' questionnaire for TCM pattern of heart failure. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 2009, 23:31-33.
8. Ge YB, Mao JY. Study on the distribution characteristics of the TCM syndromes of 7512 coronary artery disease patients. Shandong J Tradit Chin Med 2011, 4:227-229.
9. Xie DX, Huang XZ, Mao BY. Mechanisms of Qishen Yiqi dropping pills on ventricular remodeling after myocardial infarction of rat model. Chin J Exp Tradit Med Formulae 2011, 6:180-183.
10. Liu ZY, Du WX, Zhu MD, Wei Y, Song QG, Feng LM, Su JL. Effects of Qishenyiqi dripping pills on the expression of TGF-β1 mRNA in rats with acute myocardial infarction. Lishizhen Medicine and Materia Medica Research 2009, 02:331-333.
11. Feng LM, Du WX, Zhu MD, Song QG, Wei Y, Su JL, Liu ZY, Liu M. Experimental research on the collagen repair effects of Qishenyiqi dripping pills in acute myocardial infarction. Lishizhen Medicine and Materia Medica Research 2010, 12:3080-3082.
12. Wang Y, Wang J, Guo LP, Gao XM. Antiplatelet effects of Qishen Yiqi dropping pills in platelets aggregation in hyperlipidemic rabbits. Evid Based Complement Alternat Med 2012, 2012:205451. 3434420, 22969824.
13. Wu JX, Wang J, Guo LP. The influence of drop pill of Qi-shen on [Ca2+]i in intra-cellular of platelet in the rabbit with hyperlipemia. Shanxi J Tradit Chin Med 2011, 02:41-42.
14. Song YZ, Guo LP, Shang H, Wang J. Effects of Qishenyiqi dripping pills on lipid metabolism in experimental hypercholesterolemia rabbits. Jilin J Tradit Chin Med 2011, 01:71-73.
15. Du WX, Zhu MD, Feng LM, Song QG, Wei Y, Ma P, Liu ZY, Liu M. Clinical study on the effects of Qishenyiqi dripping pills on ventricular remodeling in early post-myocardial infarction. Chinese Community Doctors 2010, 11:17.
16. Xie DX, Mao BY. Effect on Qishenyiqi pills on ventricular remodeling and cardiac function of patient with Qi deficiency and blood stasis syndrome after myocardial infarction. Chin J Exp Tradit Med Formulae 2011, 01:192-195.
17. Chen TG, Tan WL, Ma ZQ, Zhong ZY, Sun GF, Zhou YX. Effect of Qishenyiqi dripping pills on heart function and serum cytokines in the patients of chronic heart failure. Chin J Gerontol 2011, 05:742-744.
18. Qi JX, Yuan RY, Li GP, Song F. Adiponectin level in patients of chronic heart failure with coronary artery disease and those interventing [sic] by Qishen Yiqi dropping pill. Shaanxi Medical Journal 2010, 12:1624-1627.
19. An YX, Zhang QS, Ding ZX. Clinical observation of Qishen Yiqi dripping pills in the treatment of ischemic heart failure. Pract J Card Cereb Pneumal Vasc Dis 2010, 03:367.
20. Hutcheon SD, Gillespie ND, Crombie IK, Struthers AD, McMurdo ME. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart 2002, 88:373-377. 10.1136/heart.88.4.373, 1767356, 12231595.
21. Mao JY, Liu CX, Wang XL, Zhang M, Li MY, Li J, Zhang C, Hou YZ. Assessment of integrative treatment program for heart failure: randomized, placebo controlled trial (phase report). 2010 Chinese Medical Doctor Association Doctor Society of Integrative Medicine Conference Abstracts 2010, 181. Chinese Medical Doctor Association Doctor Society of Integrative Medicine Conference.
22. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.
23. Jiang MX, Ruan XF, Xu Y. Effects of Kanlijian on exercise tolerance, quality of life, and frequency of heart failure aggravation in patients with chronic heart failure. Chin J Integr Med 2006, 12:94-100. 10.1007/BF02857353, 16800986.
24. Fu SF, Zhang JH, Gao XM, Xia Y, Ferrelli R, Fauci A, Guerra R, Hu LM. Clinical practice of traditional Chinese medicines for chronic heart failure. Heart Asia 2010, 2:24-27.
25. Mao J, Hou Y, Shang H, Wang H, Wang X, Zhao Y, Niu T, Cui J, Li G, Lin Q, Shi L, Jia X, Fan R, Wang B, Wang H, Ruan J. Study on the evaluation of the clinical effects of traditional Chinese medicine in heart failure by complex intervention: protocol of SECETCM-HF. Trials 2009, 10:122. 10.1186/1745-6215-10-122, 2809053, 20030859.
26. An HY, Huang LJ, Jin JS. Preliminary exploration on effect of yiqi wenyang huoxue lishui treatment on neuroendocrine system in patients with congestive heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002, 22:349-352.
27. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985, 132:919-923. 1345899, 3978515.
28. Guazzi M, Dickstein K, Vicenzi M, Arena R. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis in clinical and prognostic insights. Circ Heart Fail 2009, 2:549-555. 10.1161/CIRCHEARTFAILURE.109.881326, 19919979.